Who invested in Scorpion Therapeutics?
Scorpion Therapeutics's investors include Lightspeed Venture Partners, OrbiMed, Wellington Management, Janus Henderson Investors and Omega Funds.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$150Mraised across 1 round since 2024, from 1 source
Source recordedSEC filing: $126M sold, first sale Jul 2024
Scorpion Therapeutics's investors include Lightspeed Venture Partners, OrbiMed, Wellington Management, Janus Henderson Investors and Omega Funds.
Scorpion Therapeutics has raised $150M across 1 round since 2024.
Scorpion Therapeutics's most recent round was a Series C of $150M in Jul 2024.
Its most recent round, $150M in Jul 2024, is also its largest on record.
Scorpion Therapeutics's first round on record, in Jul 2024, was backed by Lightspeed Venture Partners, OrbiMed and Wellington Management and 2 others.
Scorpion Therapeutics's latest named round is a Series C, in Jul 2024.
Scorpion Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.